blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1979327

EP1979327 - PYRIDINE AND PYRIMIDINE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE [Right-click to bookmark this link]
StatusThe application has been refused
Status updated on  01.11.2013
Database last updated on 05.07.2024
Most recent event   Tooltip01.11.2013Refusal of applicationpublished on 04.12.2013  [2013/49]
Applicant(s)For all designated states
Janssen Pharmaceutica N.V.
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2008/42]For all designated states
Janssen Pharmaceutica, N.V.
Turnhoutseweg 30
2340 Beerse / BE
Inventor(s)01 / ANGIBAUD, Patrick, René
Johnson & Johnson Pharmaceutical Research and Development; Division of Janssen-Cilag Campus De Maigremont BP 615
F-27106 Val de Reuil Cedex / FR
02 / MARCONNET-DECRANE, Laurence, Françoise, Bernadette
Johnson & Johnson Pharmaceutical Research and Development; Division of Janssen-Cilag Campus De Maigremont BP 615
F-27106 Val de Reuil Cedex / FR
03 / ARTS, Janine
Janssen Pharmaceutica N.V. Turnhoutseweg 30
B-2340 Beerse / BE
 [2008/42]
Representative(s)Vandersteen, Pieter
Johnson & Johnson
Patent Law Department
Turnhoutseweg 30
2340 Beerse / BE
[N/P]
Former [2008/42]Vandersteen, Pieter
Janssen Pharmaceutica N.V. Turnhoutseweg 30
2340 Beerse / BE
Application number, filing date07703889.116.01.2007
[2008/42]
WO2007EP50374
Priority number, dateEP2006010057519.01.2006         Original published format: EP 06100575
[2008/42]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2007082876
Date:26.07.2007
Language:EN
[2007/30]
Type: A1 Application with search report 
No.:EP1979327
Date:15.10.2008
Language:EN
The application published by WIPO in one of the EPO official languages on 26.07.2007 takes the place of the publication of the European patent application.
[2008/42]
Search report(s)International search report - published on:EP26.07.2007
ClassificationIPC:C07D239/42, C07D213/82, C07D409/10, A61K31/506, A61P35/00
[2008/42]
CPC:
C07D213/82 (EP,US); A61P1/04 (EP); A61P11/06 (EP);
A61P11/08 (EP); A61P13/12 (EP); A61P15/08 (EP);
A61P17/00 (EP); A61P17/10 (EP); A61P17/14 (EP);
A61P19/02 (EP); A61P19/06 (EP); A61P19/08 (EP);
A61P21/04 (EP); A61P25/00 (EP); A61P25/16 (EP);
A61P25/18 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/28 (EP); A61P27/02 (EP); A61P27/16 (EP);
A61P29/00 (EP); A61P3/10 (EP); A61P31/18 (EP);
A61P33/06 (EP); A61P35/00 (EP); A61P35/02 (EP);
A61P37/02 (EP); A61P37/06 (EP); A61P37/08 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); C07D239/42 (EP,US); C07D409/12 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2008/42]
Extension statesAL19.08.2008
BA19.08.2008
HR19.08.2008
MK19.08.2008
RS19.08.2008
TitleGerman:PYRIDIN- UND PYRIMIDINDERIVATE ALS INHIBITOREN VON HISTONDEACETYLASE[2008/42]
English:PYRIDINE AND PYRIMIDINE DERIVATIVES AS INHIBITORS OF HISTONE DEACETYLASE[2008/42]
French:DÉRIVÉS DE PYRIDINE ET DE PYRIMIDINE EN TANT QU'INHIBITEURS D'HISTONE DÉSACÉTYLASE[2008/42]
Entry into regional phase19.08.2008National basic fee paid 
19.08.2008Designation fee(s) paid 
15.07.2008Examination fee paid 
Examination procedure15.07.2008Examination requested  [2008/42]
21.07.2010Despatch of a communication from the examining division (Time limit: M06)
24.01.2011Reply to a communication from the examining division
27.06.2011Despatch of a communication from the examining division (Time limit: M06)
23.12.2011Reply to a communication from the examining division
13.02.2013Cancellation of oral proceeding that was planned for 15.03.2013
15.03.2013Date of oral proceedings (cancelled)
17.07.2013Despatch of communication that the application is refused, reason: substantive examination [2013/49]
27.07.2013Application refused, date of legal effect [2013/49]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  21.07.2010
Fees paidRenewal fee
02.02.2009Renewal fee patent year 03
01.02.2010Renewal fee patent year 04
31.01.2011Renewal fee patent year 05
31.01.2012Renewal fee patent year 06
31.01.2013Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DY]WO03075929  (JANSSEN PHARMACEUTICA NV [BE], et al) [DY] 1-10* the whole document *;
 [DY]WO03092686  (ASTRAZENECA AB [SE], et al) [DY] 1-10 * the whole document *;
 [DY]WO2005030705  (METHYLGENE INC [CA], et al) [DY] 1-10 * the whole document *;
 [PA]WO2006010749  (JANSSEN PHARMACEUTICA NV [BE], et al) [PA] 1-10 * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.